Find clinical trials for Alzheimer's Disease in Nashville, TN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near Nashville, TN, USA:
designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...
Phase 2
Nashville, Tennessee, United States and 50 other locations
This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental declin...
Phase 2
Nashville, Tennessee, United States and 34 other locations
and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndr...
Phase 1, Phase 2
Nashville, Tennessee, United States and 18 other locations
is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...
Phase 3
Nashville, Tennessee, United States and 108 other locations
and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether admin ...
Phase 2
Nashville, Tennessee, United States and 96 other locations
This project will investigate the potential of Deep Brain Stimulation to improve cognitive abilities and counteract the effects of Alzheimer's...
Nashville, Tennessee, United States
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...
Phase 3
Nashville, Tennessee, United States and 290 other locations
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...
Phase 3
Nashville, Tennessee, United States and 140 other locations
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease...
Phase 3
Nashville, Tennessee, United States and 210 other locations
study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's...
Phase 2
Nashville, Tennessee, United States and 201 other locations
Clinical trials
Research sites
Resources
Legal